CXCL12 and Hyperglycemia: The local application of lactic acid bacteria transformed with a CXCL12-expressing plasmid accelerated wound closure in healthy mice, in mouse models of hyperglycemia and peripheral ischemia, as well as in an ex vivo model of human skin [31].